<p>根據 Armstrong Advisory Group Inc.最近向證券交易委員會提交的 13F 文件，該公司在 2023 年第二季度將其在 Axon Enterprise, Inc (NASDAQ:AXON - 免費報告) 的持股增加了 1,631.7%。該機構投資者在此期間購買了 669 股後，持有 710 股生物技術公司的股票。根據其最近的 SEC 文件，Armstrong Advisory Group Inc.在 Axon Enterprise 的持股價值為 588,000 美元。</p>
<p>獲取 <strong>Axon Enterprise</strong> 的提醒：</p>
<ul>
<li>為什麼 Axon 的 16% 激增預示着公共安全技術的新紀元</li>
</ul>
<p>其他對沖基金最近也增加或減少了在該公司的股份。Vanguard Group Inc.在第一季度將其在 Axon Enterprise 的股份增加了 2.2%。Vanguard Group Inc.目前擁有 8,632,008 股生物技術公司的股票，價值 4,540,005,000 美元，此前在上個季度購買了 185,571 股。Alliancebernstein L.P.在第一季度將其在 Axon Enterprise 的持股增加了 15.9%。Alliancebernstein L.P.目前擁有 1,284,935 股生物技術公司的股票，價值 675,812,000 美元，此前在上個季度購買了 175,890 股。Westfield Capital Management Co. LP 在第一季度將其在 Axon Enterprise 的持倉增加了 29.8%。Westfield Capital Management Co. LP 目前擁有 927,801 股生物技術公司的股票，價值 487,977,000 美元，此前在上個季度購買了 212,931 股。GAMMA Investing LLC 在第一季度將其在 Axon Enterprise 的持股增加了 58,725.5%。GAMMA Investing LLC 目前擁有 764,731 股生物技術公司的股票，價值 402,210,000 美元，此前在上個季度購買了 763,431 股。最後，Northern Trust Corp 在第一季度將其在 Axon Enterprise 的股份增加了 1.2%。Northern Trust Corp 目前擁有 725,720 股生物技術公司的股票，價值 381,692,000 美元，此前在上個季度購買了 8,794 股。目前 79.08% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>Axon Enterprise 的內部買賣</h2>
<p>在相關消息中，首席會計官 Jennifer H. Mak 在 9 月 15 日星期一出售了 77 股公司的股票。該股票以 760.00 美元的平均價格出售，總價值為 58,520.00 美元。交易完成後，首席會計官持有 15,003 股公司的股票，價值約為 11,402,280 美元。此次交易使其持股減少了 0.51%。該出售在 SEC 的文件中披露，可以通過此鏈接訪問。此外，首席執行官 Patrick W. Smith 在 9 月 8 日星期一出售了 10,000 股股票。該股票以 743.64 美元的平均價格出售，總交易額為 7,436,400.00 美元。交易完成後，首席執行官直接持有 3,043,982 股公司的股票，價值 2,263,626,774.48 美元。此次交易使其持股減少了 0.33%。該出售的披露信息可以在此找到。內部人士在上個季度出售了 44,932 股公司股票，價值 34,408,816 美元。公司內部人士持有公司股票的 4.40%。</p>
<h2>Axon Enterprise 股票上漲 1.1%</h2>
<ul>
<li>MarketBeat 週迴顧 – 06/02 - 06/06</li>
</ul>
<p>AXON 股票在星期一開盤價為 774.53 美元。該公司的債務與股本比率為 0.63，流動比率為 2.95，速動比率為 2.71。該公司的市值為 608 億美元，市盈率為 191.24，市盈率/增長比率為 28.43，貝塔值為 1.40。Axon Enterprise, Inc 的 52 周低點為 387.06 美元，52 周高點為 885.91 美元。該公司的 50 日簡單移動平均線為 759.97 美元，200 日簡單移動平均線為 696.68 美元。</p>
<p>Axon Enterprise (NASDAQ:AXON - 獲取免費報告) 最近在 8 月 4 日星期一發布了季度財報。該生物技術公司報告本季度每股收益為 2.12 美元，超出市場共識預期的 1.54 美元，超出幅度為 0.58 美元。Axon Enterprise 的淨利潤率為 13.64%，股本回報率為 6.80%。該公司本季度的收入為 6.6854 億美元，而分析師預期為 6.4177 億美元。與去年同期相比，該公司的季度收入增長了 32.6%。在去年同期，該公司每股收益為 1.20 美元。Axon Enterprise 已設定其 2025 財年的每股收益指導。整體而言，股票研究分析師預計 Axon Enterprise, Inc 將在當前年度發佈 5.8 美元的每股收益。</p>
<h2>華爾街分析師觀點</h2>
<ul>
<li>AXON：摩托羅拉以 44 億美元收購，競爭加劇</li>
</ul>
<p>一些研究公司最近對 AXON 發表了看法。Raymond James Financial 重申了 “跑贏大盤” 的評級，並在 8 月 5 日的研究報告中將 Axon Enterprise 的目標價上調至 855.00 美元（之前為 645.00 美元）。Zacks Research 在 9 月 2 日的研究報告中將 Axon Enterprise 的評級從 “強力買入” 下調至 “持有”。摩根大通在 7 月 17 日的研究報告中將 Axon Enterprise 的目標價從 730.00 美元上調至 850.00 美元，並給予該公司 “增持” 評級。瑞銀集團在 8 月 5 日的研究報告中重申了 “中性” 評級，並將 Axon Enterprise 的目標價上調至 840.00 美元（之前為 820.00 美元）。最後，摩根士丹利在 7 月 11 日的研究報告中設定了 Axon Enterprise 的目標價為 885.00 美元，並給予該股票 “增持” 評級。十三位研究分析師對該股票給予了買入評級，三位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，平均目標價為 837.69 美元。</p>
<p><strong>查看我們對 AXON 的最新分析</strong></p>
<h2>Axon Enterprise 公司簡介</h2>
<p>(免費報告)</p>
<p>Axon Enterprise, Inc 在美國和國際上開發、製造和銷售以 TASER 品牌為名的導電能量設備 (CEDs)。它通過兩個部門運營，分別是軟件與傳感器和 TASER。該公司還提供硬件和基於雲的軟件解決方案，使執法部門能夠捕捉、安全存儲、管理、共享和分析視頻及其他數字證據。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們認為比 Axon Enterprise 更好的股票</li>
<li>英國市場假期有哪些？如何投資和交易</li>
<li>3 只被忽視的價值股將在利率下降時激增</li>
<li>如何在 7 個步驟中投資大麻股票</li>
<li>Hims &amp; Hers 股票因醫療保健降息狂潮而飆升</li>
<li>Roth IRA 計算器：計算您的潛在回報</li>
<li>在美聯儲降息後，PNC 可能會迎來抵押貸款再融資熱潮</li>
</ul>
<p><strong>想看看其他對 AXON 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Axon Enterprise, Inc (NASDAQ:AXON - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Axon Enterprise 嗎？</h2>
<p>在考慮 Axon Enterprise 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Axon Enterprise 並不在名單上。</p>
<p>雖然 Axon Enterprise 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

AXON

<p>根據 Armstrong Advisory Group Inc.最近向證券交易委員會提交的 13F 文件，該公司在 2023 年第二季度將其在 Axon Enterprise, Inc（NASDAQ:AXON - 免費報告）中的持股增加了 1,631.7%</p>

<p>Armstrong Advisory Group Inc. increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,631.7% during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 710 shares of the biotechnology company's stock after buying an additional 669 shares during the period. Armstrong Advisory Group Inc.'s holdings in Axon Enterprise were worth $588,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根據 Armstrong Advisory Group Inc.最近向證券交易委員會提交的 13F 文件，該公司在 2023 年第二季度將其在 Axon Enterprise, Inc (NASDAQ:AXON - 免費報告) 的持股增加了 1,631.7%。該機構投資者在此期間購買了 669 股後，持有 710 股生物技術公司的股票。根據其最近的 SEC 文件，Armstrong Advisory Group Inc.在 Axon Enterprise 的持股價值為 588,000 美元。</p>
</div><p>Get <strong>Axon Enterprise</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Axon Enterprise</strong> 的提醒：</p>
</div><ul>
<li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼 Axon 的 16% 激增預示着公共安全技術的新紀元</li>
</ul>
</div><p>Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after purchasing an additional 185,571 shares in the last quarter. Alliancebernstein L.P. grew its holdings in Axon Enterprise by 15.9% during the 1st quarter. Alliancebernstein L.P. now owns 1,284,935 shares of the biotechnology company's stock valued at $675,812,000 after buying an additional 175,890 shares during the last quarter. Westfield Capital Management Co. LP increased its position in Axon Enterprise by 29.8% during the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after purchasing an additional 212,931 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock valued at $402,210,000 after purchasing an additional 763,431 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Axon Enterprise by 1.2% during the 1st quarter. Northern Trust Corp now owns 725,720 shares of the biotechnology company's stock worth $381,692,000 after purchasing an additional 8,794 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他對沖基金最近也增加或減少了在該公司的股份。Vanguard Group Inc.在第一季度將其在 Axon Enterprise 的股份增加了 2.2%。Vanguard Group Inc.目前擁有 8,632,008 股生物技術公司的股票，價值 4,540,005,000 美元，此前在上個季度購買了 185,571 股。Alliancebernstein L.P.在第一季度將其在 Axon Enterprise 的持股增加了 15.9%。Alliancebernstein L.P.目前擁有 1,284,935 股生物技術公司的股票，價值 675,812,000 美元，此前在上個季度購買了 175,890 股。Westfield Capital Management Co. LP 在第一季度將其在 Axon Enterprise 的持倉增加了 29.8%。Westfield Capital Management Co. LP 目前擁有 927,801 股生物技術公司的股票，價值 487,977,000 美元，此前在上個季度購買了 212,931 股。GAMMA Investing LLC 在第一季度將其在 Axon Enterprise 的持股增加了 58,725.5%。GAMMA Investing LLC 目前擁有 764,731 股生物技術公司的股票，價值 402,210,000 美元，此前在上個季度購買了 763,431 股。最後，Northern Trust Corp 在第一季度將其在 Axon Enterprise 的股份增加了 1.2%。Northern Trust Corp 目前擁有 725,720 股生物技術公司的股票，價值 381,692,000 美元，此前在上個季度購買了 8,794 股。目前 79.08% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Insider Buying and Selling at Axon Enterprise</h2>
<div class="lb-trans"><h2>Axon Enterprise 的內部買賣</h2>
</div><p>In related news, CAO Jennifer H. Mak sold 77 shares of the business's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer owned 15,003 shares of the company's stock, valued at approximately $11,402,280. The trade was a 0.51% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $743.64, for a total transaction of $7,436,400.00. Following the transaction, the chief executive officer directly owned 3,043,982 shares in the company, valued at $2,263,626,774.48. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,932 shares of company stock valued at $34,408,816 in the last quarter. Corporate insiders own 4.40% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，首席會計官 Jennifer H. Mak 在 9 月 15 日星期一出售了 77 股公司的股票。該股票以 760.00 美元的平均價格出售，總價值為 58,520.00 美元。交易完成後，首席會計官持有 15,003 股公司的股票，價值約為 11,402,280 美元。此次交易使其持股減少了 0.51%。該出售在 SEC 的文件中披露，可以通過此鏈接訪問。此外，首席執行官 Patrick W. Smith 在 9 月 8 日星期一出售了 10,000 股股票。該股票以 743.64 美元的平均價格出售，總交易額為 7,436,400.00 美元。交易完成後，首席執行官直接持有 3,043,982 股公司的股票，價值 2,263,626,774.48 美元。此次交易使其持股減少了 0.33%。該出售的披露信息可以在此找到。內部人士在上個季度出售了 44,932 股公司股票，價值 34,408,816 美元。公司內部人士持有公司股票的 4.40%。</p>
</div><h2>Axon Enterprise Stock Up 1.1%</h2>
<div class="lb-trans"><h2>Axon Enterprise 股票上漲 1.1%</h2>
</div><ul>
<li>MarketBeat Week in Review – 06/02 - 06/06</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 06/02 - 06/06</li>
</ul>
</div><p>AXON stock opened at $774.53 on Monday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The firm has a market capitalization of $60.80 billion, a P/E ratio of 191.24, a P/E/G ratio of 28.43 and a beta of 1.40. Axon Enterprise, Inc has a 52-week low of $387.06 and a 52-week high of $885.91. The company's 50 day simple moving average is $759.97 and its 200-day simple moving average is $696.68.</p>
<div class="lb-trans"><p>AXON 股票在星期一開盤價為 774.53 美元。該公司的債務與股本比率為 0.63，流動比率為 2.95，速動比率為 2.71。該公司的市值為 608 億美元，市盈率為 191.24，市盈率/增長比率為 28.43，貝塔值為 1.40。Axon Enterprise, Inc 的 52 周低點為 387.06 美元，52 周高點為 885.91 美元。該公司的 50 日簡單移動平均線為 759.97 美元，200 日簡單移動平均線為 696.68 美元。</p>
</div><p>Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. The company's quarterly revenue was up 32.6% compared to the same quarter last year. During the same period in the previous year, the company posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.</p>
<div class="lb-trans"><p>Axon Enterprise (NASDAQ:AXON - 獲取免費報告) 最近在 8 月 4 日星期一發布了季度財報。該生物技術公司報告本季度每股收益為 2.12 美元，超出市場共識預期的 1.54 美元，超出幅度為 0.58 美元。Axon Enterprise 的淨利潤率為 13.64%，股本回報率為 6.80%。該公司本季度的收入為 6.6854 億美元，而分析師預期為 6.4177 億美元。與去年同期相比，該公司的季度收入增長了 32.6%。在去年同期，該公司每股收益為 1.20 美元。Axon Enterprise 已設定其 2025 財年的每股收益指導。整體而言，股票研究分析師預計 Axon Enterprise, Inc 將在當前年度發佈 5.8 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><ul>
<li>AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition</li>
</ul>
<div class="lb-trans"><ul>
<li>AXON：摩托羅拉以 44 億美元收購，競爭加劇</li>
</ul>
</div><p>A number of research firms have recently weighed in on AXON. Raymond James Financial reissued an &#34;outperform&#34; rating and issued a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Zacks Research lowered Axon Enterprise from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, September 2nd. JPMorgan Chase &amp; Co. lifted their price objective on Axon Enterprise from $730.00 to $850.00 and gave the company an &#34;overweight&#34; rating in a research report on Thursday, July 17th. UBS Group reiterated a &#34;neutral&#34; rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the stock an &#34;overweight&#34; rating in a research note on Friday, July 11th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and an average price target of $837.69.</p>
<div class="lb-trans"><p>一些研究公司最近對 AXON 發表了看法。Raymond James Financial 重申了 “跑贏大盤” 的評級，並在 8 月 5 日的研究報告中將 Axon Enterprise 的目標價上調至 855.00 美元（之前為 645.00 美元）。Zacks Research 在 9 月 2 日的研究報告中將 Axon Enterprise 的評級從 “強力買入” 下調至 “持有”。摩根大通在 7 月 17 日的研究報告中將 Axon Enterprise 的目標價從 730.00 美元上調至 850.00 美元，並給予該公司 “增持” 評級。瑞銀集團在 8 月 5 日的研究報告中重申了 “中性” 評級，並將 Axon Enterprise 的目標價上調至 840.00 美元（之前為 820.00 美元）。最後，摩根士丹利在 7 月 11 日的研究報告中設定了 Axon Enterprise 的目標價為 885.00 美元，並給予該股票 “增持” 評級。十三位研究分析師對該股票給予了買入評級，三位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的平均評級為 “適度買入”，平均目標價為 837.69 美元。</p>
</div><p><strong>View Our Latest Analysis on AXON</strong></p>
<div class="lb-trans"><p><strong>查看我們對 AXON 的最新分析</strong></p>
</div><h2>Axon Enterprise Company Profile</h2>
<div class="lb-trans"><h2>Axon Enterprise 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.</p>
<div class="lb-trans"><p>Axon Enterprise, Inc 在美國和國際上開發、製造和銷售以 TASER 品牌為名的導電能量設備 (CEDs)。它通過兩個部門運營，分別是軟件與傳感器和 TASER。該公司還提供硬件和基於雲的軟件解決方案，使執法部門能夠捕捉、安全存儲、管理、共享和分析視頻及其他數字證據。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Axon Enterprise</li>
<li>What Are the U.K. Market Holidays? How to Invest and Trade</li>
<li>3 Overlooked Value Stocks Set to Surge as Rates Drop</li>
<li>How to invest in marijuana stocks in 7 steps</li>
<li>Hims &amp; Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy</li>
<li>Roth IRA Calculator: Calculate Your Potential Returns</li>
<li>After the Fed's Rate Cut, PNC Could See a Mortgage Refinance Boom</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 Axon Enterprise 更好的股票</li>
<li>英國市場假期有哪些？如何投資和交易</li>
<li>3 只被忽視的價值股將在利率下降時激增</li>
<li>如何在 7 個步驟中投資大麻股票</li>
<li>Hims &amp; Hers 股票因醫療保健降息狂潮而飆升</li>
<li>Roth IRA 計算器：計算您的潛在回報</li>
<li>在美聯儲降息後，PNC 可能會迎來抵押貸款再融資熱潮</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding AXON?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 AXON 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Axon Enterprise, Inc (NASDAQ:AXON - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVhPTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=AXON"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Axon Enterprise Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Axon Enterprise 嗎？</h2>
</div><p>Before you consider Axon Enterprise, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Axon Enterprise 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Axon Enterprise 並不在名單上。</p>
</div><p>While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Axon Enterprise 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Armstrong Advisory Group Inc. 收購了 Axon Enterprise, Inc 的 $AXON 股票